Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
Advances in therapy
View this publicationMember
Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53127 Bonn
Advances in therapy
View this publicationAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
View this publicationDrugs
View this publication